Tretamine or triethylenemelamine

This classification denotes an ethylenimine compound with the molecular formula C9H12N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F7IY6HZG9D, chemically known as 2,4,6-tris(ethylenimino)-s-triazine but more generally known as tretamine, which bears US NIH Compound Identifier 5799. European Medicines Agency schedules Tretamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11243MIG. The term TRETAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). TRETAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Tretamine or triethylenemelamine bears US NLM identifiers UMLS ID C0040975 and NCI Concept Code C29858. SMILES: N1(CC1)C1NC(N2CC2)NC(N2CC2)N1.